HB927

Louisiana HB927 amends the Medicaid Pharmaceutical and Therapeutics Committee, adding a physician or pharmacist from each Medicaid managed care.

Louisiana HB927 modifies the composition of the Medicaid Pharmaceutical and Therapeutics Committee by adding one physician or pharmacist from each Medicaid managed care organization. The bill also removes restrictions on prior authorization for anti-retroviral prescription drugs prescribed for the treatment and prevention of HIV/AIDS. These changes aim to enhance the committee's expertise and ensure broader access to necessary HIV/AIDS medications under Medicaid.